Oaktree invests in Draslovka
Submitted by:
Andrew Warmington
Oaktree Capital Management is to invest $150 million in Czech firm Draslovka, “providing preferred equity
Draslovka: One done, one denied
Submitted by:
Andrew Warmington
Draslovka, a specialist in cyanide chemistry based in the Czech Republic, has completed the previously
Czech firm buys Chemours’ mining business
Submitted by:
Andrew Warmington
Draslovka, a multi-family-owned Czech speciality chemicals firm, has agreed to acquire the Mining Solutions business
PFAS claims in Delaware settled
Submitted by:
Andrew Warmington
DuPont and the companies that used to be part of it, Chemours and Corteva, have
Chemours announces net zero goals
Submitted by:
Andrew Warmington
Chemours has announced plans to achieve a 60% absolute reduction of operations-related greenhouse gas emissions
Chemours divides business segment
Submitted by:
Andrew Warmington
Chemours has divided its former Fluoroproducts segment into two new reportable segments under newly appointed
DuPont settles with Chemours
Submitted by:
Andrew Warmington
DuPont, its spin-off company Chemours, and Corteva, which unites DuPont’s and Dow’s former agrochemicals businesses
Feature Article – Covid-19 update: How the industry is responding
Submitted by:
Andrew Warmington
The news is entirely dominated by the coronavirus pandemic. Here, we summaries some of the
Round one to DuPont over Chemours in legal battle
Submitted by:
Andrew Warmington
The first step in ongoing litigation in the US between Chemours and its parent firm
Chemours opens 'Discovery Hub'
Submitted by:
Andrew Warmington
Chemours has formally inaugurated its new innovation centre, the Chemours Discovery Hub, on the University